Quantcast

Latest ViroPharma Stories

2014-08-13 08:28:28

PHILADELPHIA, Aug. 13, 2014 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015. Separately, Tarsa announced that Daniel Soland has...

2014-06-16 08:29:08

Company will draw on leaders' expertise in rare diseases, R&D and commercialization as it moves to complete development of its lead program in inherited blindness PHILADELPHIA, June 16, 2014 /PRNewswire/ -- Spark Therapeutics, a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today the appointments of Lars Ekman, former president of research and development at Elan, and Vin Milano, former president and CEO of...

2014-05-06 23:15:12

Dr. Peabody brings intellectual property rights experience to the natural pharmaceutical company to move the organization forward. Palm Beach County, FL (PRWEB) May 06, 2014 Sancilio & Company (SCI), a biopharmaceutical company that specializes in the development of preventative, natural pharmaceuticals, has announced the addition of Dr. John D. Peabody to their management team. Dr. Peabody joins SCI as Chief Legal Officer and Vice President of Strategic Development. He comes to the...

2014-02-25 08:31:20

EXTON, Pennsylvania, February 25, 2014 /PRNewswire/ -- ViroPharma Incorporated today announced the results of its tender offer (the "Convertible Notes Tender Offer") pursuant to which each holder of the 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes") had the right (the "Fundamental Change Repurchase Right") to require ViroPharma to repurchase all of such holder's Convertible Notes, or any portion thereof that is a multiple of $1,000 principal amount, on...

2014-01-24 16:22:11

EXTON, Pennsylvania, January 24, 2014 /PRNewswire/ -- ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes"). Earlier in the day on January 24, 2014, Shire completed the tender...

2014-01-24 08:23:53

DUBLIN, January 24, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful completion of the tender offer for all of the outstanding shares of ViroPharma (NASDAQ: VPHM). The tender offer expired at midnight, New York City time, on Thursday, January 23, 2014 (one minute after 11:59 p.m., New York City time, on January 23, 2014), and was not extended. As of midnight on January 23, 2014, approximately 53,745,956 common shares of ViroPharma...

2014-01-15 12:25:40

DUBLIN, January 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has waived the Office of Fair Trading (OFT) approval condition to the announced tender offer for all of the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM). As a result of the waiver, the transaction is no longer conditional on OFT approval, and Shire expects to complete the tender offer on January 24, 2014 following the currently scheduled expiration time, subject...

2014-01-10 04:20:37

DUBLIN, January 10, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the expiration of its previously announced tender offer by a wholly owned subsidiary of Shire for all of the outstanding common shares of ViroPharma Incorporated (NASDAQ: VPHM) until midnight, New York City time, on Thursday, January 23, 2014 (one minute after 11:59 p.m., New York City time, on January 23, 2014). The tender offer had previously been scheduled to expire...

2013-12-27 04:21:49

DUBLIN, December 27, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the expiration of its previously announced tender offer by a wholly owned subsidiary of Shire for all of the outstanding common shares of ViroPharma (NASDAQ: VPHM) until midnight, New York City time, on Thursday, January 9, 2014 (one minute after 11:59 p.m., New York City time, on January 9, 2014). The tender offer had previously been scheduled to expire at 6:00 p.m.,...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related